Vascularization predicts overall survival and risk of transformation in follicular lymphoma
- PMID: 20713461
- PMCID: PMC2995576
- DOI: 10.3324/haematol.2009.021766
Vascularization predicts overall survival and risk of transformation in follicular lymphoma
Abstract
Follicular lymphoma patients display heterogeneous overall survival and variable risk of transformation. Recent studies have highlighted the role of the microenvironment. The contribution of microvessel density to follicular lymphoma survival remains controversial. We used a quantitative tumor mapping approach to determine whether the degree of vascularization correlated with outcome in a uniformly treated cohort. Whole-tissue sections of diagnostic biopsies from 84 cases were stained for CD34 and tumor-to-vessel-distance that encompassed 90% of the tumor (TVD(90)) was determined using image analysis. Twenty-one cases with lower TVD(90) showed inferior overall survival (P=0.0001) and high risk of transformation (P=0.01). These cases significantly correlated with increased Lymphoma-Associated Macrophages (χ(2)=0.025). In multivariate analysis macrophages content, IPI and TVD(90) were independent predictors of overall survival (P=0.05, P=0.001 and P=0.01, respectively) and IPI and TVD(90) predicted risk of transformation (P=0.008 and P=0.08, respectively). Increased angiogenesis is an independent marker of inferior survival and may promote transformation.
Figures
Similar articles
-
Increased vascularization predicts favorable outcome in follicular lymphoma.Clin Cancer Res. 2005 Jan 1;11(1):154-61. Clin Cancer Res. 2005. PMID: 15671540
-
Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.Ultrastruct Pathol. 2012 Oct;36(5):336-42. doi: 10.3109/01913123.2012.672847. Epub 2012 May 10. Ultrastruct Pathol. 2012. PMID: 22574784
-
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Clin Cancer Res. 2014 Jun 1;20(11):2862-72. doi: 10.1158/1078-0432.CCR-13-2367. Epub 2014 Apr 11. Clin Cancer Res. 2014. PMID: 24727328 Free PMC article.
-
Treatment of Histologic Transformation.Hematol Oncol Clin North Am. 2020 Aug;34(4):785-794. doi: 10.1016/j.hoc.2020.03.001. Epub 2020 May 5. Hematol Oncol Clin North Am. 2020. PMID: 32586581 Review.
-
Transformed follicular lymphoma.Ann Hematol. 2018 Jan;97(1):17-29. doi: 10.1007/s00277-017-3151-2. Epub 2017 Oct 18. Ann Hematol. 2018. PMID: 29043381 Review.
Cited by
-
Advances in the multi-omics landscape of follicular lymphoma.Int J Biol Sci. 2023 Mar 27;19(6):1955-1967. doi: 10.7150/ijbs.80401. eCollection 2023. Int J Biol Sci. 2023. PMID: 37063433 Free PMC article. Review.
-
Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitals.Hematol Transfus Cell Ther. 2018 Oct-Dec;40(4):343-353. doi: 10.1016/j.htct.2018.02.004. Epub 2018 Apr 18. Hematol Transfus Cell Ther. 2018. PMID: 30370412 Free PMC article.
-
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.Front Immunol. 2018 Oct 1;9:2264. doi: 10.3389/fimmu.2018.02264. eCollection 2018. Front Immunol. 2018. PMID: 30327655 Free PMC article. Review.
-
Lymph node ultrasound in lymphoproliferative disorders: clinical characteristics and applications.J Basic Clin Physiol Pharmacol. 2025 Jun 3;36(4):275-284. doi: 10.1515/jbcpp-2025-0089. eCollection 2025 Jul 1. J Basic Clin Physiol Pharmacol. 2025. PMID: 40459902 Review.
-
Pathogenesis of follicular lymphoma.J Clin Invest. 2012 Oct;122(10):3424-31. doi: 10.1172/JCI63186. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023713 Free PMC article. Review.
References
-
- Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol. 2008;26(32):5165–9. - PubMed
-
- Montoto S, Lopez-Guillermo A, Altes A, Perea G, Ferrer A, Camos M, et al. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol. 2004;15(10):1484–9. - PubMed
-
- Vacca A, Ribatti D. Bone marrow angiogenesis in multiple myeloma. Leukemia. 2006;20(2):193–9. - PubMed
-
- Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A. The history of the angiogenic switch concept. Leukemia. 2007;21(1):44–52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources